Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases

. 2018 Jan ; 72 (1) : 87-92. [epub] 20170628

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid28656971

BACKGROUND/OBJECTIVES: Phenylketonuria (PKU) and several other inherited metabolic diseases (IMD) require a lifelong low-protein diet (LPD), otherwise they lead to many health complications. LPDs, however, carry a significant economic burden for patients and their families. The objective of this study was to explore the costs of low-protein foods (LPFs) necessary for LPD as well as dietary patterns and compliance towards an LPD. SUBJECTS/METHODS: A detailed questionnaire was created in cooperation with National Association of PKU and other IMD (NSPKU), and consequently sent to all NSPKU members treated with an LPD (n=303). A total of 184 respondents from the Czech Republic were included in the study (174 had PKU, 10 had other IMD). RESULTS: The average daily consumption of LPF was equal to 411.7 g (PKU) and 345.6 g (other IMD), which corresponds to energy value of 5558 kJ and 4438 kJ, respectively, per patient per day. Patients mostly consumed low-protein flour (≈30% of energy intake), pasta (≈18%), basic pastry (≈15%) and sweets (≈10%). The average monthly costs of LPDs were equal to [euro ]130 (PKU) and [euro ]129 (other IMD) per patient per month. The compliance with LPD was decreasing with increasing age (P<0.0001). CONCLUSIONS: This is the largest study examining costs and dietary patterns of LPDs in patients with PKU and the first study of this kind in other IMD patients requiring an LPD. The study clearly showed that an LPD carries a very high economic burden for families, which may lead to less LPD compliance and potential severe health consequences.

Zobrazit více v PubMed

Mol Genet Metab. 2011;104 Suppl:S26-30 PubMed

Mol Genet Metab. 2014 Jul;112(3):210-7 PubMed

J Inherit Metab Dis. 2004;27(2):115-25 PubMed

J Pediatr. 2014 Apr;164(4):895-899.e2 PubMed

Mol Genet Metab. 2013 Dec;110(4):418-23 PubMed

Mol Genet Metab. 2013 Jul;109(3):237-42 PubMed

Eur J Clin Nutr. 2011 Feb;65(2):275-8 PubMed

J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S415-8 PubMed

Orphanet J Rare Dis. 2014 Sep 02;9:130 PubMed

Eur J Health Econ. 2017 Jan;18(1):73-82 PubMed

Mol Genet Metab. 2013 Dec;110(4):424-30 PubMed

J Inherit Metab Dis. 2007 Apr;30(2):202-8 PubMed

Mol Genet Metab. 2012 Mar;105(3):390-4 PubMed

Lancet. 2010 Oct 23;376(9750):1417-27 PubMed

Mol Genet Metab. 2007 Sep-Oct;92(1-2):63-70 PubMed

J Inherit Metab Dis. 2017 Jan;40(1):49-74 PubMed

J Intellect Disabil Res. 1999 Feb;43 ( Pt 1):30-7 PubMed

J Inherit Metab Dis. 1995;18(3):347-53 PubMed

Orphanet J Rare Dis. 2013 Dec 17;8:191 PubMed

Adv Exp Med Biol. 2010;686:397-431 PubMed

Acta Paediatr. 2011 Aug;100(8):1144-9 PubMed

Eur J Pediatr. 2015 Jan;174(1):119-27 PubMed

Orphanet J Rare Dis. 2015 Dec 22;10:162 PubMed

Eur J Pediatr. 1996 Jul;155 Suppl 1:S90-2 PubMed

Psychosomatics. 2012 Nov-Dec;53(6):517-23 PubMed

Neurosci Biobehav Rev. 2009 Mar;33(3):414-21 PubMed

Orphanet J Rare Dis. 2013 Jan 11;8:8 PubMed

Eur J Pediatr. 2000 Oct;159 Suppl 2:S74-9 PubMed

Mol Genet Metab. 2014 Jun;112(2):87-122 PubMed

Eur J Clin Nutr. 2016 Jul;70(7):785-9 PubMed

J Inherit Metab Dis. 2017 May;40(3):369-376 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...